Price History
Feb 9, 2026 — May 18, 2026Investment Snapshot
- P/B of 1.53 — trading above book value
- Piotroski F-Score 5/9 — moderate financial health
- Loss-making — negative ROE of -35.1%
- High dividend yield of 6.4%
DENTSPLY SIRONA Inc. - Common Stock (XRAY) is a Healthcare company operating in Dental Equipment & Supplies, listed on the NASDAQ , with a market capitalisation of $2.0 billion . Key value metrics: P/B ratio 1.53, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
DENTSPLY SIRONA Inc. - Common Stock — Fundamental Analysis Summary
On financial health, XRAY shows a moderate Piotroski F-Score of 5/9, and negative return on equity of -35.1% (sector average: -20.6%), and elevated leverage with a debt-to-equity ratio of 1.70.
StockPik's composite Value Score for XRAY is 68/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
XRAY reports a solid gross margin of 50.7% (sector average: 40.1%) and a negative operating margin of -8.8%.
XRAY shows revenue declining at 3% year-over-year, with earnings growing at 34%.
XRAY pays a high dividend yield of 6.4%.